Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-22-003104
Filing Date
2022-02-03
Accepted
2022-02-03 16:20:09
Documents
72

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 4980419
2 ex23-1.htm EX-23.1 3722
3 CALCULATION OF REGISTRATION FEE ex107.htm EX-FILING FEES 7377
4 image_001.jpg GRAPHIC 69549
5 logo_001.jpg GRAPHIC 3628
  Complete submission text file 0001493152-22-003104.txt   16479413

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ppcb-20210930.xsd EX-101.SCH 79781
7 XBRL CALCULATION FILE ppcb-20210930_cal.xml EX-101.CAL 74959
8 XBRL DEFINITION FILE ppcb-20210930_def.xml EX-101.DEF 336928
9 XBRL LABEL FILE ppcb-20210930_lab.xml EX-101.LAB 627895
10 XBRL PRESENTATION FILE ppcb-20210930_pre.xml EX-101.PRE 463124
66 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 2806732
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-262493 | Film No.: 22588568
SIC: 2834 Pharmaceutical Preparations